USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity
Vital Signs - Over the Patent Cliff: Suing the FDA is the Latest Action by Branded and Generics Pharmaceutical Companies Battling for Market Opportunity
RELEASE DATE
07-Mar-2013
07-Mar-2013
REGION
North America
North America
Research Code: 9561-00-F3-00-00
SKU: LS00245-NA-MR_17659
$1,500.00
In stock
SKU
LS00245-NA-MR_17659
Description
This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies.
Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.
Table of Contents
This week's issue
Popular Topics
This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies.
Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.
| No Index | Yes |
|---|---|
| Podcast | No |
| WIP Number | 9561-00-F3-00-00 |
| Is Prebook | No |